InvestorsHub Logo
Followers 126
Posts 15347
Boards Moderated 2
Alias Born 06/29/2006

Re: None

Monday, 07/24/2017 9:20:15 AM

Monday, July 24, 2017 9:20:15 AM

Post# of 27552
Anyone read? New Sticky • Comments about what you hold would be welcomed

Those that don't hold is obviously noticed and I'll believe I'll put those on IGNORE BUTTON even tho we share a Board • Chow with dog if you want as Science is on FAIMS and OUR Dr Yost is leading the Crowd of the Future

If you read it, Read It Again • Future is waiting

At the University of Florida, Professor Rick Yost is high on FAIMS, a technology that he envisions as a fast, mobile platform for molecular detection. "Nobody has a good commercial device that does what we know [FAIMS] can do," he said, but he's got several applications in mind.

One is a breathalyzer for marijuana. Yost is scientific advisor to a Canadian company called Cannabix that is working on such a device. FAIMS devices can be as small as a book of matches, he said, and water vapor actually helps improve the technique. "It's a hot topic for either medical purposes or recreation," he said. Many states have passed laws prescribing a legal limit for THC in the blood, but don't have a field-ready test for it, he said.

He's also launched a spinout called Breathtec, which is looking for biomarkers in the breath. "Diabetes, fatty liver disease, we know these things impact the breath," Yost said. While it might be a stretch to use breath for a definitive diagnosis, he suggested it could be used as a first-line screening method for something like fatty liver disease, which requires a biopsy for diagnosis.


https://www.genomeweb.com/proteomics-protein-research/commercial-adoption-ion-mobility-technology-drives-multi-omics

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News